Deal facts
- Buyer
- Milton Chen
- Target
- VSee Lab, Inc.
- Deal value
- Not disclosed
- Announced
- 5 June 2026
- Status
- Completed
- Sector
- Healthcare
- Country
- United States
- Consideration
- shares
Sources
Milton Chen has agreed to acquire the assets of VSee Lab, Inc. in a management buyout structure. The transaction involves consideration in the form of shares, with the deal classified as an asset sale within the Healthcare sector. Both the buyer and the target are based in the United States. Although the specific financial value of the transaction was not disclosed, the deal was announced on 5 June 2026 and subsequently completed on 31 May 2026.
The acquisition marks a significant transition for the healthcare technology firm, allowing the new owner to assume control of the business assets. This arrangement enables the continuation of operations under fresh ownership without the need for a full corporate merger. The transaction is now complete following the finalisation of the asset transfer and share consideration.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
Milton Chen completes acquisition of VSee Lab, Inc.
Item 1.01 Entry into a Material Definitive Agreement. On May 31, 2026, VSee Health, Inc., a Delaware corporation (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Milton Chen, the Company’s co-Chief Executive Officer and Chairman of the Board and the Chief Executive Officer of VSee Lab, Inc., a Delaware Corporation and wholly-owned subsidiary of the Company (“
Source
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
COMREF Chiron IRF, LLC to acquire Chiron Real Estate Inc.
COMREF Chiron IRF, LLC has agreed to acquire Chiron Real Estate Inc. in an asset sale valued at USD 217 million. The transaction, which involves cash consideration only,…
- Buyer
- COMREF Chiron IRF, LLC
- Target
- Chiron Real Estate Inc.
- Deal value
- USD 217,000,000
- Deal type
- asset sale
Nuvo Pharmaceuticals (Ireland) DAC to acquire Cumberland Pharmaceuticals Inc.
Nuvo Pharmaceuticals (Ireland) DAC has agreed to acquire the assets of Cumberland Pharmaceuticals Inc. in a cash transaction valued at USD 100 million. The deal, classif…
- Buyer
- Nuvo Pharmaceuticals (Ireland) DAC
- Target
- Cumberland Pharmaceuticals Inc.
- Deal value
- USD 100,000,000
- Deal type
- asset sale
GA SNF ABBEVILLE GA LLC and GA SNF EASTMAN GA LLC to acquire Selectis Health, Inc.
GA SNF ABBEVILLE GA LLC and GA SNF EASTMAN GA LLC and Selectis Health, Inc. entered the Exit Mode archive.
- Buyer
- GA SNF ABBEVILLE GA LLC and GA SNF EASTMAN GA LLC
- Target
- Selectis Health, Inc.
- Deal value
- USD 15,700,000
- Deal type
- asset sale
MeiraGTx Holdings plc to acquire Janssen Pharmaceuticals, Inc.
MeiraGTx Holdings plc and Janssen Pharmaceuticals, Inc. entered the Exit Mode archive.
- Buyer
- MeiraGTx Holdings plc
- Target
- Janssen Pharmaceuticals, Inc.
- Deal value
- USD 25,000,000
- Deal type
- asset sale
Supernus Pharmaceuticals, Inc. to acquire Navitor Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. and Navitor Pharmaceuticals, Inc. entered the Exit Mode archive.
- Buyer
- Supernus Pharmaceuticals, Inc.
- Target
- Navitor Pharmaceuticals, Inc.
- Deal value
- USD 350,000,000
- Deal type
- asset sale
Buyer history
Milton Chen
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive